$LIN

LINDE PLC (LIN): Results of Operations and Financial Condition

LINDE PLC (LIN) filed an SEC Form 8-K — Results of Operations and Financial Condition. lin_8k.htm 0001707925 false 0001707925 2026-07-31 2026-07-31 0001707925 dei:OtherAddressMember 2026-07-31 2026-07-31 iso4217:USD xbrli:shares iso4217:USD xbrli:shares UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTI

Original reporting
Published Jul 31, 2026, 11:24 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 31, 2026, 11:27 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$LIN
Neutral
low confidence
Mentioned
$LIN
Relevance
7/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$LINNeutralLow
01

Why it matters

Because the provided text does not include the earnings numbers, margins, cash flow, or guidance, the actionable trading takeaway from this scrape is limited to confirmation that results were released and filed.

02

Market read

This filing is the mechanism for distributing quarterly results, but the scrape does not contain the content traders need to assess upside or downside.

03

What to watch

The trading signal depends entirely on Exhibit 99.1 figures and any guidance or outlook language, which are not present in the provided body.

Relevance 7/10Novelty 2/10Timing: filed July 31, 2026 pre-market/early session (07:24 ET)

Background

The SEC 8-K (Item 2.02) reports that Linde plc issued a press release with results for the quarter ended June 30, 2026, attached as Exhibit 99.1.

Company-level read

Ticker impact

$LINNeutralLow confidence
Context

Linde plc filed an 8-K stating it issued a press release with results for the quarter ended June 30, 2026, furnished as Exhibit 99.1.

Expected impact

Near-term price reaction is possible once traders access Exhibit 99.1 details, but this specific text provides no numbers to trade on.

Evidence & confidence

The filing confirms the results release occurred and was attached, yet the article body contains only procedural 8-K language without the earnings metrics that would drive valuation changes.

Market effects

Limited from this text, since no segment margins, demand commentary, or guidance details are provided.

None determinable from the scraped 8-K wrapper alone.

None determinable without the attached Exhibit 99.1 financial results.

Counterpoint

Traders may already have the earnings details from other feeds; this wrapper-only scrape may add little incremental value versus the actual Exhibit 99.1 content.

Key entities

  • Linde plc

    Subject of the SEC 8-K filing, reporting quarterly results via Exhibit 99.1.

  • Exhibit 99.1

    The attached press release containing the actual results, not included in the scraped body.

Related articles

$LINMed

Linde (LIN) vs. Air Products (APD): Racing for the Chip Boom

Linde (LIN) said it won a long-term supply agreement for ultra-high-purity industrial gases to a major semiconductor manufacturer, with a $1 billion Phoenix, Arizona investment and two SPECTRA air separation units. Linde’s Taiwan JV plans about $800 million for related expansion. Linde reported Q2 sales of $9.29 billion and adjusted EPS $4.50. Air Products (APD) also won a Taiwan semiconductor-related infrastructure deal.

$LINMed

$1B Arizona project to boost gas supply for advanced chipmaking

Linde said it will invest $1 billion to expand on-site ultra-high-purity industrial gas production at a Phoenix, Arizona complex under a long-term supply agreement with an unnamed semiconductor manufacturer. The gases (nitrogen, oxygen, argon) will support two new fabrication plants. Linde LienHwa will invest about $800 million in Taiwan for industrial gas and hydrogen facilities for the same customer.

$LINMed

Linde plc Q2 2026 Earnings Call Summary

Linde plc reported record Q2 sales and near double-digit EPS growth, with a record $8.1 billion project backlog after electronics wins in the Western U.S. Operating margins excluding cost pass-through fell 30 bps due to U.S. homecare (Lincare) headwinds and a mix shift. Full-year EPS guidance raised to $17.70-$17.90; helium normalization expected early 2027.

$LINMed

Why is Linde stock sliding today?

Investing.com reports Linde shares fell about 5.9% to $478.87 after its Q2 2026 earnings release showed margin pressure despite a top and bottom line beat. Adjusted EPS was $4.50 (+10% YoY) on $9.3B sales (+9%), but adjusted operating margin fell to 29.5%. Full-year 2026 guidance stayed at $17.70–$17.90 and Q3 at $4.45–$4.55.

$LINMed

Linde to invest $1 billion in Arizona for semiconductor gases

Linde (NYSE:LIN) said it secured a long-term contract to supply ultra-high-purity industrial gases to a major semiconductor manufacturer and will invest about $1 billion in Arizona. The deal includes building, owning, and operating two air separation units to expand supply of nitrogen, oxygen, and argon for two new fabs. Linde’s Taiwan JV plans about $800 million for the same customer.

$LINMedAI 9/10

Linde plc: Linde Reports Second-Quarter 2026 Results

Second-Quarter Highlights Sales $9.3 billion, up 9% YoY, underlying sales up 4% Operating profit $2.6 billion, adjusted operating profit $2.7 billion, up 7% Operating profit margin 27.5%; adjusted operating profit margin 29.5% EPS $4.15, up 11%; adjusted EPS $4.50, up 10% YoY Second-quarter operating cash flow of $2.3 billion, up 3% YoY Full-year 2026 adjusted EPS guidance of $17.70 $17.90 representing 8% to 9% growth Project backlog $11 billion Linde plc (Nasdaq: LIN) today reported...